Changing the Practice of Medicine
Popular
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Alessandra Tedeschi, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Aditya Bardia, MD, MPH, FASCO
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
CME/CE
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Erica L. Mayer, MD, MPH
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
Michael Dolinger, MD, MBA
David T. Rubin, MD
Florence Odufalu, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Clinical Practice
- MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Programs
Aditya Bardia, MD, MPH, FASCO
- Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
- MinuteCE®
Translating Advances into Practice: Lessons from Today’s IBD Landscape
2.00 program creditsUgo Iroku, MD, MHS
David T. Rubin, MD
Ugo Iroku, MD, MHS
Michael Dolinger, MD, MBA
David T. Rubin, MD
- CME/CE Broadcast Replay
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
1.00 creditRobert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD